mit

Susan E. Erdman


Dr Susan Erdman


Research Support

  Funding

  • R01 CA108854 07:  ROLE OF IL10 AND TGFB1 IN COLON CANCER; PI: ERDMAN, SUSAN
  • U01 CA164337:
    GI TRACT DYSBIOSIS AND BREAST CANCER; PI: ERDMAN, SUSAN
  • ES002109 32: PILOT PROJECT PROGRAM, CEHS; PI: ERDMAN, SUSAN AND ALM, ERIC
These projects are supported by grants from the National Institute of Health (NIH).
 

Collaborations

The Erdman Laboratory works with leading researchers and institutions worldwide:

  • Cancer Prevention Institute of California
  • Columbia University
  • Harvard Medical School
  • MIT
  • Thessoliniki University
  • U. Mass Medical, MA
  • Yale University, CT
  • Dana Farber, MA

Research Interests

We work with a synergistic team of scientists with diverse backgrounds, training and institutional environments with the unified goal of targeting inflammatory processes in disease and in health.  My background in Comparative Medicine at Massachusetts Institute of Technology (MIT) and postdoctoral training from Harvard School of Public Health provides unique expertise in animal models of immunology and cancer, integrated with a global perspective on human health.

immunity

Regulatory T Cells (TREG) Inhibit non-B non-T Colitis and Cancer

Brief Key Findings

  • Regulatory TREG cells inhibit non-B non-T colitis (2001) [1].
  • Gut bacteria-triggered innate immunity is sufficient for cancer (2003) [3].
  • Enteropathogenic gut bacteria trigger extra-intestinal cancer (2006) [6].
  • Earlier microbe exposures facilitate immune balance and prevent cancer (2006) [6].
  • Feeding of sterile microbes is sufficient for immune balance (2010) [15].
  • Adoptive transfer of immune cells increases lifespan (2010) [15].
  • Gut bacteria, IL10, and mucosal immunity unify cancer with other inflammatory disorders (2010) [7], [17].
  • microbes
  • Oral microbe therapy heals wounds 2X faster, promotes healthful aging, healthy skin and hair, prevents age-associated weight gain, and may prevent some types of cancer. (2013) [21], [19], [18].

©2001-2013 All Rights Reserved
Valid XHTML & CSS | Portions of design by P. Heard and OSWD